RÉSUMÉ
BACKGROUND: Multiple endocrine neoplasias (MENs) are a group of hereditary diseases involving multiple endocrine glands, and their prevalence is low. MEN type 1 (MEN1) has diverse clinical manifestations, mainly involving the parathyroid glands, gastrointestinal tract, pancreas and pituitary gland, making it easy to miss the clinical diagnosis. CASE SUMMARY: We present the case of a patient in whom MEN1 was detected early. A middle-aged male with recurrent abdominal pain and diarrhea was admitted to the hospital. Blood tests at admission revealed hypercalcemia and hypophosphatemia, and emission computed tomography of the parathyroid glands revealed a hyperfunctioning parathyroid lesion. Gastroscopy findings suggested a duodenal bulge and ulceration. Ultrasound endoscopy revealed a hypoechoic lesion in the duodenal bulb. Further blood tests revealed elevated levels of serum gastrin. Surgery was performed, and pathological analysis of the surgical specimens revealed a parathyroid adenoma after parathyroidectomy and a neuroendocrine tumor after duodenal bulbectomy. The time from onset to the definitive diagnosis of MEN1 was only approximately 1 year. CONCLUSION: For patients who present with gastrointestinal symptoms accompanied by hypercalcemia and hypophosphatemia, clinicians need to be alert to the possibility of MEN1.
Sujet(s)
Hypercalcémie , Néoplasie endocrinienne multiple de type 1 , Tumeurs de la parathyroïde , Parathyroïdectomie , Humains , Néoplasie endocrinienne multiple de type 1/chirurgie , Néoplasie endocrinienne multiple de type 1/diagnostic , Néoplasie endocrinienne multiple de type 1/complications , Néoplasie endocrinienne multiple de type 1/anatomopathologie , Mâle , Tumeurs de la parathyroïde/chirurgie , Tumeurs de la parathyroïde/diagnostic , Tumeurs de la parathyroïde/anatomopathologie , Tumeurs de la parathyroïde/complications , Adulte d'âge moyen , Hypercalcémie/diagnostic , Hypercalcémie/étiologie , Hypercalcémie/sang , Adénomes/chirurgie , Adénomes/diagnostic , Adénomes/anatomopathologie , Adénomes/sang , Tumeurs du duodénum/chirurgie , Tumeurs du duodénum/diagnostic , Tumeurs du duodénum/anatomopathologie , Hypophosphatémie/étiologie , Hypophosphatémie/diagnostic , Douleur abdominale/étiologie , Douleur abdominale/diagnostic , Tumeurs neuroendocrines/chirurgie , Tumeurs neuroendocrines/diagnostic , Tumeurs neuroendocrines/sang , Tumeurs neuroendocrines/anatomopathologie , Diarrhée/étiologie , Diarrhée/diagnostic , Dépistage précoce du cancer/méthodes , Gastroscopie , Résultat thérapeutiqueRÉSUMÉ
Primary hyperparathyroidism (PHPT) is the most prevalent cause of hypercalcaemia, affecting 0.3% of the population. The only curative procedure is parathyroidectomy. Ectopic adenomas are challenging to localize and frequently result in persistent PHPT. This is a case report of a 29-year-old male patient who was diagnosed with PHPT prior to neck surgery and reoperated with bilateral neck exploration. However, the PHPT was not cured, until diagnostic CT with contrast had helped localizing a 1 cm ectopic parathyroid adenoma in the right horn of the thymus gland. The adenoma was then removed successfully.
Sujet(s)
Adénomes , Hyperparathyroïdie primitive , Tumeurs de la parathyroïde , Tomodensitométrie , Humains , Mâle , Adulte , Tumeurs de la parathyroïde/imagerie diagnostique , Tumeurs de la parathyroïde/chirurgie , Tumeurs de la parathyroïde/anatomopathologie , Adénomes/imagerie diagnostique , Adénomes/chirurgie , Adénomes/anatomopathologie , Hyperparathyroïdie primitive/chirurgie , Hyperparathyroïdie primitive/imagerie diagnostique , Hyperparathyroïdie primitive/étiologie , Choristome/imagerie diagnostique , Choristome/chirurgie , Choristome/anatomopathologie , ParathyroïdectomieRÉSUMÉ
BACKGROUND: Parathyroid carcinoma (PC) is a rare malignancy, often diagnosed incidentally through postoperative pathological examination. The occurrence of nodular goiter, intrathyroidal parathyroid carcinoma, contralateral parathyroid adenoma (PA), and papillary thyroid microcarcinoma (PTMC) is extremely uncommon, which prompted us to report our case experience. CASE PRESENTATION: We describe a 67-year-old male who presented with a cervical mass causing tracheal compression, which prompted him to seek medical advice. Based on preoperative auxiliary examination results from color Doppler ultrasound, SPECT parathyroid imaging, and blood tests, he was initially diagnosed with a suspected parathyroid adenoma and nodular goiter. Excision of the right lobe and isthmus of the thyroid, and left superior parathyroid gland was conducted, which were sent to intraoperative frozen pathological examination. During intraoperative observation, adhesion around the right thyroid lobe was discovered. Consequently, right central area lymph node dissection was performed due to suspicion of an aggressive malignant tumor. Histology and immunohistochemistry analysis revealed incidental intrathyroidal parathyroid carcinoma, contralateral parathyroid adenoma, classical papillary thyroid microcarcinoma, and nodular goiter. CONCLUSION: Parathyroid carcinoma should be highly suspected when extremely high levels of PTH and severe hypercalcemia are present, which cannot be simply explained by a preoperatively localized parathyroid adenoma, especially when suspicious malignant adhesion is found during intraoperative exploration. In cases where multifocal thyroid nodules are associated with increased uptake of 99Tc-sestamibi, the possibility of coexisting carcinomas should be considered, not only for thyroid malignancy but also for the potential presence of intrathyroidal parathyroid carcinoma.
Sujet(s)
Carcinome papillaire , Hyperparathyroïdie primitive , Tumeurs primitives multiples , Tumeurs de la parathyroïde , Tumeurs de la thyroïde , Humains , Mâle , Tumeurs de la parathyroïde/chirurgie , Tumeurs de la parathyroïde/anatomopathologie , Tumeurs de la parathyroïde/imagerie diagnostique , Tumeurs de la parathyroïde/diagnostic , Tumeurs de la thyroïde/anatomopathologie , Tumeurs de la thyroïde/chirurgie , Tumeurs de la thyroïde/diagnostic , Sujet âgé , Carcinome papillaire/anatomopathologie , Carcinome papillaire/chirurgie , Carcinome papillaire/diagnostic , Carcinome papillaire/imagerie diagnostique , Hyperparathyroïdie primitive/chirurgie , Hyperparathyroïdie primitive/étiologie , Hyperparathyroïdie primitive/anatomopathologie , Hyperparathyroïdie primitive/diagnostic , Tumeurs primitives multiples/anatomopathologie , Tumeurs primitives multiples/chirurgie , Tumeurs primitives multiples/diagnostic , Résultats fortuitsRÉSUMÉ
Variations in parathyroid gland positions often cause failure in initial parathyroid adenoma surgery, especially when imaging fails to localise the adenoma. This report describes a female patient with primary hyperparathyroidism for which preoperative localisation studies did not determine the position of the hyperfunctioning gland. The initial approach with bilateral cervical exploration and intraoperative parathyroid hormone monitoring was performed unsuccessfully. A mediastinal adenoma was suspected due to meticulous negative neck exploration and repeated negative images for a neck adenoma. Subsequently, a second approach involving mediastinal exploration was performed. After the removal of remnant thymic tissue in the mediastinal space, a significant drop in intraoperative parathyroid hormone levels was achieved. The pathological result confirmed the presence of a tiny pathological parathyroid adenoma within the thymus. At 6 months follow-up, postoperative biochemical assessment was consistent with normal calcium and parathyroid hormone levels.
Sujet(s)
Adénomes , Hyperparathyroïdie primitive , Tumeurs de la parathyroïde , Humains , Tumeurs de la parathyroïde/complications , Tumeurs de la parathyroïde/chirurgie , Tumeurs de la parathyroïde/imagerie diagnostique , Femelle , Hyperparathyroïdie primitive/chirurgie , Hyperparathyroïdie primitive/étiologie , Hyperparathyroïdie primitive/complications , Hyperparathyroïdie primitive/diagnostic , Hyperparathyroïdie primitive/imagerie diagnostique , Adénomes/complications , Adénomes/chirurgie , Adénomes/imagerie diagnostique , Tumeurs du médiastin/complications , Tumeurs du médiastin/imagerie diagnostique , Tumeurs du médiastin/chirurgie , Hormone parathyroïdienne/sang , Adulte d'âge moyen , Glandes parathyroïdes/imagerie diagnostique , ParathyroïdectomieRÉSUMÉ
BACKGROUND: Hypercalcemia can be a rare contributor to acute pancreatitis (AP) in pregnancy. This is primarily due to primary hyperparathyroidism (PHPT), resulting from parathyroid carcinoma. We exhibited a case report to analyze the diagnosis and treatment during the onset of hypercalcemia-induced AP. CASE PRESENTATION: A 32-year-old primigravida presented with acute pancreatitis near full-term gestation. Following a cesarean delivery, there was a reduction in serum amylase and peripancreatic exudate, but her serum calcium concentrations persistently elevated over 4.0 mmol/L. Interventions to lower the hypercalcemia were only temporarily effective, until a high serum parathyroid hormone (PTH) concentration of 1404 pg/mL was detected. Ultrasound revealed a 31 mm × 24 mm hypoechoic oval nodule in the left lower lobe of the thyroid gland. She underwent a parathyroidectomy, resulting in a dramatic decrease in serum PTH level, from preoperative levels of 2051 pg/mL to 299 pg/mL just 20 minutes after removal. Similarly, her serum calcium declined from 3.82 mmol/L to 1.73 mmol/L within 24 hours postoperatively. The final histopathology suggested parathyroid carcinoma. CONCLUSION: When refractory hypercalcemia is present, serum PTH levels should be measured to determine PHPT. Parathyroidectomy is the optimal strategy for alleviating hypercalcemia and clarifying the underlying pathology.
Sujet(s)
Hypercalcémie , Pancréatite , Tumeurs de la parathyroïde , Parathyroïdectomie , Complications tumorales de la grossesse , Troisième trimestre de grossesse , Humains , Femelle , Hypercalcémie/étiologie , Hypercalcémie/sang , Tumeurs de la parathyroïde/complications , Tumeurs de la parathyroïde/chirurgie , Grossesse , Adulte , Pancréatite/étiologie , Pancréatite/complications , Pancréatite/sang , Complications tumorales de la grossesse/chirurgie , Hormone parathyroïdienne/sang , Hyperparathyroïdie primitive/chirurgie , Hyperparathyroïdie primitive/complications , Hyperparathyroïdie primitive/sang , Césarienne , Calcium/sangRÉSUMÉ
Importance: Whether F18-choline (FCH) positron emission tomographic (PET)/computed tomographic (CT) scan can replace Tc99m-sestaMIBI (MIBI) single-photon emission (SPE)CT/CT as a first-line imaging technique for preoperative localization of parathyroid adenomas (PTA) in patients with primary hyperparathyroidism (PHPT) is unclear. Objective: To compare first-line FCH PET/CT vs MIBI SPECT/CT for optimal care in patients with PHPT needing parathyroidectomy and to compare the proportions of patients in whom the first-line imaging method resulted in successful minimally invasive parathyroidectomy (MIP) and normalization of calcemia 1 month after surgery. Design, Setting, and Participants: A French multicenter randomized open diagnostic intervention phase 3 trial was conducted. Patients were enrolled from November 2019 to May 2022 and participated up to 6 months after surgery. The study included adults with PHPT and an indication for surgical treatment. Patients with previous parathyroid surgery or multiple endocrine neoplasia type 1 (MEN1) were ineligible. Interventions: Patients were assigned in a 1:1 ratio to receive first-line FCH PET/CT (FCH1) or MIBI SPECT/CT (MIBI1). In the event of negative or inconclusive first-line imaging, they received second-line FCH PET/CT (FCH2) after MIBI1 or MIBI SPECT/CT (MIBI2) after FCH1. All patients underwent surgery under general anesthesia within 12 weeks following the last imaging. Clinical and biologic (serum calcemia and parathyroid hormone levels) assessments were performed 1 and 6 months after surgery. Main Outcomes and Measures: The primary outcome was a true-positive first-line imaging-guided MIP combined with uncorrected serum calcium levels of 2.55 mmol/l or less 1 month after surgery, corresponding to the local upper limit of normality. Results: Overall, 57 patients received FCH1 (n = 29) or MIBI1 (n = 28). The mean (SD) age of patients was 62.8 (12.5) years with 15 male (26%) and 42 female (74%) patients. Baseline patient characteristics were similar between groups. Normocalcemia at 1 month after positive first-line imaging-guided MIP was observed in 23 of 27 patients (85%) in the FCH1 group and 14 of 25 patients (56%) in the MIBI1 group. Sensitivity was 82% (95% CI, 62%-93%) and 63% (95% CI, 42%-80%) for FCH1 and MIBI1, respectively. Follow-up at 6 months with biochemical measures was available in 43 patients, confirming that all patients with normocalcemia at 1 month after surgery still had it at 6 months. No adverse events related to imaging and 4 adverse events related to surgery were reported. Conclusions: This randomized clinical trial found that first-line FCH PET/CT is a suitable and safe replacement for MIBI SPECT/CT. FCH PET/CT leads more patients with PHPT to correct imaging-guided MIP and normocalcemia than MIBI SPECT/CT thanks to its superior sensitivity. Trial Registration: ClinicalTrials.gov Identifier: NCT04040946.
Sujet(s)
Choline , Hyperparathyroïdie primitive , Parathyroïdectomie , Tomographie par émission de positons couplée à la tomodensitométrie , Radiopharmaceutiques , Technétium (99mTc) sestamibi , Humains , Femelle , Mâle , Hyperparathyroïdie primitive/chirurgie , Hyperparathyroïdie primitive/imagerie diagnostique , Hyperparathyroïdie primitive/sang , Adulte d'âge moyen , Tomographie par émission de positons couplée à la tomodensitométrie/méthodes , Parathyroïdectomie/méthodes , Sujet âgé , Radio-isotopes du fluor , Tumeurs de la parathyroïde/chirurgie , Tumeurs de la parathyroïde/imagerie diagnostique , Tumeurs de la parathyroïde/complications , Adénomes/chirurgie , Adénomes/imagerie diagnostiqueRÉSUMÉ
Technetium-99m sestamibi single-photon emission computed tomography/computed tomography (99mTc-sestamibi SPECT/CT) is a mainstay of the pre-operative localization of parathyroid lesions. We report here the case of a 30 year-old woman with a fortuitously discovered 2 cm cervical mass for which a parathyroid origin was originally suspected due to its retro-thyroidal localization and a personal history of nephrolithiasis. Normal serum calcium and parathyroid hormone (PTH) levels excluded primary hyperparathyroidism, raising suspicion of a non-functional parathyroid adenoma, and SPECT/CT imaging showed that the mass was 99mTc-sestamibi-avid. Fine-needle aspiration (FNA) was performed; cytology was non-diagnostic but the needle washout was negative for thyroglobulin, calcitonin and PTH, arguing against a thyroidal or parathyroidal origin of the mass. Core needle biopsy revealed a schwannoma, ostensibly originating from the recurrent laryngeal nerve; upon surgical resection, it was finally found to arise from the esophageal submucosa. This case illustrates the fact that endocrinologists, radiologists, nuclear medicine, head and neck, and other specialists investigating patients with cervical masses should be aware that schwannomas need to be considered in the differential diagnosis of focal 99mTc-sestamibi uptake in the neck region.
Sujet(s)
Adénomes , Neurinome , Tumeurs de la parathyroïde , Technétium (99mTc) sestamibi , Humains , Femelle , Tumeurs de la parathyroïde/imagerie diagnostique , Tumeurs de la parathyroïde/anatomopathologie , Tumeurs de la parathyroïde/chirurgie , Tumeurs de la parathyroïde/diagnostic , Adulte , Neurinome/imagerie diagnostique , Neurinome/anatomopathologie , Neurinome/diagnostic , Diagnostic différentiel , Adénomes/imagerie diagnostique , Adénomes/diagnostic , Adénomes/anatomopathologie , Adénomes/métabolisme , Tumeurs de l'oesophage/imagerie diagnostique , Tumeurs de l'oesophage/diagnostic , Tumeurs de l'oesophage/anatomopathologie , Tumeurs de l'oesophage/chirurgie , Tomographie par émission monophotonique couplée à la tomodensitométrie , RadiopharmaceutiquesRÉSUMÉ
<b><br>Introduction:</b> Primary hyperparathyroidism (PHPT) is mainly caused by parathyroid adenoma (PA). Rare variants of PA, weighing >2.0-3.5 g are called "large" or "giant" adenomas and account for about 1.5% of all PA.</br> <b><br>Aim:</b> The aim of this study was to compare normal-sized and large parathyroid lesions identifying risk factors for severe hypercalcemia.</br> <b><br>Materials and methods:</b> 27 patients with PHPT and parathyroid lesion ≥2.0 cm3 (study group) were compared with 73 patients with PHPT and lesion < 2.0 cm<sup>3</sup> (control group). In both groups, the majority were women (81.5% - study group, 90.5% - control group, gender ratios 4.4:9.1, respectively). The patients were examined preoperatively and postoperatively: PTH, creatine, calcium, and phosphate serum and urine concentrations, and calcidiol serum levels were assessed. Preoperative ultrasonography (US) was performed.</br> <b><br>Results:</b> Patients with larger parathyroid lesions had signifficantly higher PTH and calcium serum concentrations and lower serum phosphate and calcidiol concentrations. There were no statistically significant differences in the concentration of creatine in serum and urine, calciuria, or tubular reabsorption of phosphorus (TRP). US relatively underestimated the parathyroid volume by about 0.3-0.4 mL (10% in larger lesions and 43% in smaller ones).</br> <b><br>Conclusions:</b> Due to higher PTH and calcium levels, larger parathyroid adenomas may constitute a higher risk of severe hypercalcemia. In general, US underestimated the parathyroid volume.</br>.
Sujet(s)
Adénomes , Hypercalcémie , Tumeurs de la parathyroïde , Humains , Hypercalcémie/étiologie , Hypercalcémie/sang , Hypercalcémie/diagnostic , Tumeurs de la parathyroïde/chirurgie , Tumeurs de la parathyroïde/complications , Tumeurs de la parathyroïde/sang , Femelle , Mâle , Adulte d'âge moyen , Adénomes/chirurgie , Adénomes/complications , Adénomes/sang , Adulte , Sujet âgé , Facteurs de risque , Hyperparathyroïdie primitive/chirurgie , Hyperparathyroïdie primitive/sang , Hyperparathyroïdie primitive/complications , Calcium/sang , ParathyroïdectomieRÉSUMÉ
Primary hyperparathyroidism can be sporadic or part of a genetic syndrome, such as MEN1 or HPT-JT. Diagnosis of hereditary HPT requires a thorough history and physical. Parathyroidectomy is curative with greater than 95% success. However, some patients have persistent or recurrent disease requiring reoperation. Reoperative parathyroidectomy is technically challenging, and localizing the pathologic gland can difficult. Patients needing reoperation should undergo evaluation by a high-volume surgeon. Care should be taken to obtain all of the preoperative workup and operative note from the initial surgery. Radioguided parathyroidectomy can be safely and effectively performed in patients with hereditary HPT or undergoing reoperative surgery.
Sujet(s)
Hyperparathyroïdie primitive , Parathyroïdectomie , Récidive , Humains , Hyperparathyroïdie primitive/chirurgie , Hyperparathyroïdie primitive/diagnostic , Hyperparathyroïdie primitive/génétique , Parathyroïdectomie/méthodes , Réintervention , Tumeurs de la parathyroïde/chirurgie , Tumeurs de la parathyroïde/génétique , Tumeurs de la parathyroïde/diagnostic , Tumeurs de la parathyroïde/complicationsRÉSUMÉ
Primary hyperparathyroidism (PHPT) is a disorder characterized by the autonomous overproduction of parathyroid hormone (PTH) that leads to hypercalcemia, multiple clinical sequelae, and heterogenous presentation. Whether PHPT is caused by a single benign adenoma (85%), multiglandular disease (15%), or parathyroid carcinoma (1%), surgery is the definitive treatment.
Sujet(s)
Hyperparathyroïdie primitive , Tumeurs de la parathyroïde , Parathyroïdectomie , Humains , Hyperparathyroïdie primitive/diagnostic , Hyperparathyroïdie primitive/chirurgie , Hyperparathyroïdie primitive/complications , Hyperparathyroïdie primitive/thérapie , Parathyroïdectomie/méthodes , Tumeurs de la parathyroïde/complications , Tumeurs de la parathyroïde/chirurgie , Tumeurs de la parathyroïde/diagnostic , Hormone parathyroïdienne/sang , Hormone parathyroïdienne/métabolisme , Hypercalcémie/étiologie , Hypercalcémie/diagnostic , Hypercalcémie/thérapie , Adénomes/complications , Adénomes/chirurgie , Adénomes/diagnosticRÉSUMÉ
We aimed to provide an in-depth analysis with respect to three turning points in pancreas involvement in primary hyperparathyroidism (PHP): hypercalcemia-induced pancreatitis (HCa-P), MEN1 (multiple endocrine neoplasia)-related neuroendocrine tumors (NETs), and insulin resistance (IR). This was a comprehensive review conducted via a PubMed search between January 2020 and January 2024. HCa-P (n = 9 studies, N = 1375) involved as a starting point parathyroid NETs (n = 7) or pancreatitis (n = 2, N = 167). Case report-focused analysis (N = 27) showed five cases of pregnancy PHP-HCa-P and three reports of parathyroid carcinoma (female/male ratio of 2/1, ages of 34 in women, men of 56). MEN1-NET studies (n = 7) included MEN1-related insulinomas (n = 2) or MEN1-associated PHP (n = 2) or analyses of genetic profile (n = 3), for a total of 877 MEN1 subjects. In MEN1 insulinomas (N = 77), the rate of associated PHP was 78%. Recurrence after parathyroidectomy (N = 585 with PHP) was higher after less-than-subtotal versus subtotal parathyroidectomy (68% versus 45%, p < 0.001); re-do surgery was 26% depending on surgery for pancreatic NETs (found in 82% of PHP patients). MEN1 pathogenic variants in exon 10 represented an independent risk factor for PHP recurrence. A single pediatric study in MEN1 (N = 80) revealed the following: a PHP rate of 80% and pancreatic NET rate of 35% and 35 underlying germline MEN1 pathogenic variants (and 3/35 of them were newly detected). The co-occurrence of genetic anomalies included the following: CDC73 gene variant, glucokinase regulatory protein gene pathogenic variant (c.151C>T, p.Arg51*), and CAH-X syndrome. IR/metabolic feature-focused analysis identified (n = 10, N = 1010) a heterogeneous spectrum: approximately one-third of adults might have had prediabetes, almost half displayed some level of IR as reflected by HOMA-IR > 2.6, and serum calcium was positively correlated with HOMA-IR. Vitamin D deficiency was associated with a higher rate of metabolic syndrome (n = 1). Normocalcemic and mildly symptomatic hyperparathyroidism (n = 6, N = 193) was associated with a higher fasting glucose and some improvement after parathyroidectomy. This multilayer pancreas/parathyroid analysis highlighted a complex panel of connections from pathogenic factors, including biochemical, molecular, genetic, and metabolic factors, to a clinical multidisciplinary panel.
Sujet(s)
Hypercalcémie , Hyperparathyroïdie primitive , Insulinorésistance , Pancréatite , Humains , Hyperparathyroïdie primitive/génétique , Hyperparathyroïdie primitive/chirurgie , Hyperparathyroïdie primitive/complications , Insulinorésistance/génétique , Hypercalcémie/génétique , Hypercalcémie/étiologie , Pancréatite/génétique , Pancréatite/étiologie , Femelle , Mâle , Protéines proto-oncogènes/génétique , Tumeurs du pancréas/génétique , Tumeurs du pancréas/anatomopathologie , Tumeurs du pancréas/complications , Néoplasie endocrinienne multiple de type 1/génétique , Néoplasie endocrinienne multiple de type 1/complications , Tumeurs de la parathyroïde/génétique , Tumeurs de la parathyroïde/complications , Tumeurs de la parathyroïde/chirurgie , Adulte , Parathyroïdectomie , Tumeurs neuroendocrines/génétique , Tumeurs neuroendocrines/complications , Tumeurs neuroendocrines/anatomopathologie , Pancréas/anatomopathologie , Pancréas/chirurgie , Pancréas/métabolismeRÉSUMÉ
Primary hyperparathyroidism (PHPT) is rare in pregnancy. This condition is challenging to diagnose and manage due to the limited diagnostic and therapeutic options that are safe during pregnancy. If not diagnosed and managed in a timely manner, serious maternal and foetal complications may occur. We report two cases, one with surgical intervention and one without, to show the importance of timely surgical intervention and discuss the challenges in the management of PHPT in pregnancy.
Sujet(s)
Hyperparathyroïdie primitive , Humains , Femelle , Grossesse , Hyperparathyroïdie primitive/diagnostic , Hyperparathyroïdie primitive/chirurgie , Hyperparathyroïdie primitive/complications , Adulte , Complications de la grossesse/diagnostic , Tumeurs de la parathyroïde/chirurgie , Tumeurs de la parathyroïde/complications , Tumeurs de la parathyroïde/diagnostic , Parathyroïdectomie , Complications tumorales de la grossesse/chirurgie , Adénomes/chirurgie , Adénomes/complications , Adénomes/diagnostic , Résultat thérapeutiqueRÉSUMÉ
We present successful surgical treatment of a patient with chronic kidney disease (CKD) and hyperparathyroidism undergoing renal replacement therapy. At baseline, parathyroidectomy via cervical access was performed for parathyroid adenomas. After 6 years, clinical and laboratory relapse of disease required thoracoscopic resection of atypically located anterior mediastinal adenoma. This case demonstrates that this disease is one of the most difficult in modern medicine requiring a special approach in diagnosis and treatment. Patients with CKD and hyperparathyroidism need for follow-up, control of total and ionized serum calcium, inorganic phosphorus and parathormone, osteodensitometry, ultrasound and scintigraphy of thyroid and parathyroid glands, and, if necessary, CT or MRI of the neck and chest organs.
Sujet(s)
Adénomes , Tumeurs de la parathyroïde , Parathyroïdectomie , Humains , Tumeurs de la parathyroïde/chirurgie , Tumeurs de la parathyroïde/complications , Tumeurs de la parathyroïde/diagnostic , Parathyroïdectomie/méthodes , Adénomes/chirurgie , Adénomes/complications , Adénomes/diagnostic , Résultat thérapeutique , Récidive tumorale locale/chirurgie , Glandes parathyroïdes/chirurgie , Adulte d'âge moyen , Thoracoscopie/méthodes , Mâle , Femelle , Tumeurs du médiastin/chirurgie , Tumeurs du médiastin/complications , Tumeurs du médiastin/diagnostic , Hyperparathyroïdie secondaire/chirurgie , Hyperparathyroïdie secondaire/étiologie , Hyperparathyroïdie secondaire/diagnostic , Insuffisance rénale chronique/complications , Insuffisance rénale chronique/diagnostic , Médiastin/chirurgieSujet(s)
Adénomes , Fluorodésoxyglucose F18 , Imagerie par résonance magnétique , Tumeurs de la parathyroïde , Tomographie par émission de positons couplée à la tomodensitométrie , Tomodensitométrie , Humains , Tumeurs de la parathyroïde/imagerie diagnostique , Tumeurs de la parathyroïde/chirurgie , Tumeurs de la parathyroïde/complications , Tomographie par émission de positons couplée à la tomodensitométrie/méthodes , Adénomes/imagerie diagnostique , Adénomes/anatomopathologie , Adénomes/chirurgie , Tumeurs osseuses/imagerie diagnostique , Radiopharmaceutiques , Femelle , Mâle , Adulte d'âge moyenRÉSUMÉ
Thoracic surgery is increasingly influenced by the development of minimally invasive approaches which have also influenced surgery in the area of the anterior mediastinum. The previously standard approach to the thymus via partial sternotomy was gradually replaced by the videothoracoscopic approach in most cases. In recent years, robotically assisted surgery has been gaining ground worldwide in this area, as well. The aim of our paper is to provide a comprehensive overview of procedures in the field of the thymus, including their indications, and to share our first experience with robot-assisted thymus surgery. At the 3rd Department of Surgery, since the start of the robot-assisted thymus surgery program, 23 thymectomies have been performed using this approach, of which 17 were performed for thymoma, 3 for myasthenia gravis, and 3 for parathyroid adenoma localized in thymus tissue. From our experience and the available data, it follows that the length of hospitalization, the rate of complications and the resulting effect of robot-assisted procedures is comparable to VTS procedures; however, the robot-assisted surgery also allows for mini-invasive treatment even in significantly obese patients and in patients with advanced thymic tumors who would otherwise be indicated for open thymectomy.
Sujet(s)
Myasthénie , Interventions chirurgicales robotisées , Thymectomie , Thymome , Tumeurs du thymus , Humains , Interventions chirurgicales robotisées/méthodes , Thymectomie/méthodes , Tumeurs du thymus/chirurgie , Thymome/chirurgie , Myasthénie/chirurgie , Tumeurs de la parathyroïde/chirurgie , Thymus (glande)/chirurgie , MâleRÉSUMÉ
BACKGROUND: Detective flow imaging (DFI) is a new imaging technology that displays low-velocity blood flow, which is difficult to visualize on conventional color Doppler ultrasonography (CDU). In this study, we compared the usefulness of DFI with that of CDU and methoxy-isobutyl-isonitrile (MIBI) scintigraphy for detecting parathyroid adenoma (PA) in patients with primary hyperparathyroidism (PHPT). METHODS: From March 2021 to March 2023, 87 PHPT patients underwent surgery, and 66 had a single PA. We performed preoperative conventional ultrasonography with CDU, MIBI scintigraphy, and DFI for 42 patients (5 males and 37 females; mean age: 61.6 ± 15.4 years). RESULTS: MIBI scintigraphy detected PA in 85.7% (36/42) patients, and both CDU and DFI detected PA in all patients. The rates of vascularity in PA detected by CDU and DFI were 71.4% (30/42) and 85.7% (36/42), respectively. Vascularity was detected by DFI in 6 patients who were negative for vascularity on MIBI scintigraphy. Furthermore, DFI detected blood supply in 6 of the 12 patients with undetectable blood supply on CDU. Fisher's exact test revealed that high or low blood flow, as determined by DFI, was significantly associated with detection of feeding vessels in PA by CDU (P < 0.001). CONCLUSIONS: DFI was useful for preoperative detection of PA blood flow.
Sujet(s)
Adénomes , Hyperparathyroïdie primitive , Tumeurs de la parathyroïde , Échographie-doppler couleur , Humains , Femelle , Mâle , Adulte d'âge moyen , Tumeurs de la parathyroïde/imagerie diagnostique , Tumeurs de la parathyroïde/chirurgie , Tumeurs de la parathyroïde/complications , Hyperparathyroïdie primitive/imagerie diagnostique , Hyperparathyroïdie primitive/chirurgie , Sujet âgé , Échographie-doppler couleur/méthodes , Adénomes/imagerie diagnostique , Scintigraphie/méthodes , Technétium (99mTc) sestamibi , Adulte , Vitesse du flux sanguinRÉSUMÉ
RATIONALE: Primary hyperparathyroidism, though relatively prevalent among endocrine disorders, affecting 1% of the general population, often presents diagnostic challenges. Given its potential to precipitate severe complications including nephrolithiasis and fractures, timely diagnosis, and effective management are crucial. PATIENT CONCERNS: A 38-year-old woman with hypercalcemia was referred to the Department of Nuclear Medicine for a Tc-99m MIBI scan. DIAGNOSES: Tc-99m MIBI scan showed focal increased uptake in the left thyroid gland area, initially suggesting a parathyroid adenoma. Further examination using SPECT/CT revealed a nodular lesion within the left thyroid gland showing high Tc-99m MIBI uptake. INTERVENTIONS: Left thyroid lumpectomy confirmed the lesion as follicular thyroid carcinoma. On the second Tc-99m MIBI scan conducted after total thyroidectomy, a parathyroid adenoma was eventually detected in the right lower area, enabling the subsequent appropriate treatment, a right lower parathyroidectomy. OUTCOMES: Thirteen days after the parathyroidectomy, serum levels of total calcium and parathyroid hormone returned to normal. Furthermore, bone mineral density evaluated using DEXA remained within the expected range for her age even after 14 months. LESSONS: When interpreting the Tc-99m MIBI scan, it is essential to keep in mind that various tumors rich in mitochondria, such as thyroid carcinoma, could show a high uptake of Tc-99m MIBI.
Sujet(s)
Adénocarcinome folliculaire , Résultats fortuits , Tumeurs de la parathyroïde , Technétium (99mTc) sestamibi , Humains , Femelle , Adulte , Tumeurs de la parathyroïde/imagerie diagnostique , Tumeurs de la parathyroïde/chirurgie , Tumeurs de la parathyroïde/diagnostic , Adénocarcinome folliculaire/imagerie diagnostique , Adénocarcinome folliculaire/diagnostic , Adénocarcinome folliculaire/chirurgie , Diagnostic différentiel , Tumeurs de la thyroïde/imagerie diagnostique , Tumeurs de la thyroïde/diagnostic , Radiopharmaceutiques , Adénomes/imagerie diagnostique , Adénomes/diagnostic , Adénomes/chirurgie , Tomographie par émission monophotonique couplée à la tomodensitométrie/méthodesRÉSUMÉ
PURPOSE: For minimally invasive surgery of parathyroid adenomas, exact localization diagnostics are essential. Main imaging modalities used for diagnostics are sonography, SPECT with/without CT (traditional imaging) and 18F-choline-PET. The aim of our study was to identify predictors for inconclusive SPECT imaging and subsequently determine in which cases 18F-choline-PET is needed. METHODS: Retrospective analysis of 138 patients with histologically confirmed primary hyperparathyroidism (pHPT). After sonography, patients underwent SPECT or SPECT/CT imaging, with subsequent 18F-choline-PET in cases of disconcordant results. Logistic regression analysis was used to identify clinical and laboratory factors predictive for negative SPECT results. RESULTS: Sensitivity rates for sonography, SPECT, SPECT/CT, and choline-PET were 47 %, 49 %, 71.7 %, and 97 %, respectively. Logistic regression revealed lower PTH levels (p < 0.001), presence of structural thyroid disease (p = 0.018), and negative sonography (p < 0.001) as predictive of negative/equivocal SPECT outcome. An additional traditional imaging CT scan to a SPECT enhanced detection odds, as did greater adenoma weight. Urolithiasis, osteoporosis, and calcium values as measurement of activity and duration of disease showed no significant association with the detection rate. Furthermore, our study demonstrated that 18F-choline-PET exhibited remarkable sensitivity in detecting adenomas among patients with negative/equivocal SPECT results. CONCLUSION: Our study reveals potential predictive factors for a negative/equivocal SPECT outcome in pHPT. Identifying these factors might allow minimizing futile SPECT examinations and perhaps encourage timely utilization of 18F-choline-PET imaging. Our study reinforces the clinical significance of 18F-choline-PET, especially in complex cases with disconcordant results by conventional parathyroid imaging methods.
Sujet(s)
Choline , Hyperparathyroïdie primitive , Tumeurs de la parathyroïde , Tomographie par émission monophotonique , Humains , Hyperparathyroïdie primitive/imagerie diagnostique , Hyperparathyroïdie primitive/chirurgie , Mâle , Femelle , Adulte d'âge moyen , Études rétrospectives , Choline/analogues et dérivés , Sujet âgé , Tumeurs de la parathyroïde/imagerie diagnostique , Tumeurs de la parathyroïde/chirurgie , Tumeurs de la parathyroïde/complications , Tomographie par émission monophotonique/méthodes , Adénomes/imagerie diagnostique , Adénomes/chirurgie , Tomographie par émission de positons/méthodes , Adulte , Valeur prédictive des tests , Échographie/méthodes , Sensibilité et spécificité , Radio-isotopes du fluor , RadiopharmaceutiquesRÉSUMÉ
BACKGROUND: This study aimed to establish the standardized procedure of trans-areola single site endoscopic parathyroidectomy (TASSEP), and to compare the performance of TASSEP with that of conventional open parathyroidectomy (COP). METHODS: This study enrolled 40 patients with primary hyperparathyroidism (PHPT) who underwent TASSEP, and included 40 of 176 PHPT patients who underwent COP based on propensity score matching. The retrospective analysis was conducted based on prospectively collected data. Perioperative outcomes, including surgical profile, surgical burden and cosmetic results and follow-up were reported. The learning curve was described using a cumulative sum (CUSUM) analysis. RESULTS: 40 TASSEPs were completed successfully without conversions or severe complications. There was no statistically significant difference in operation time between TASSEP and COP groups (80.83 ± 11.95 vs. 76.95 ± 7.30 min, p = 0.084). Experience of 17 cases was necessitated to reach the learning curve of TASSEP. Postoperative pain score and traumatic index (C-reactive protein and erythrocyte sedimentation rate) in TASSEP were apparently lower than those in COP group (p < 0.05). During the proliferation and stabilization phases, TASSEP was associated with significantly better incision recovery and cosmetic scores. Postoperative serum calcium and PTH levels throughout the follow-up period indicated satisfactory surgical qualities in both groups. CONCLUSION: Based on precise preoperative localization and intraoperative planning facilitated by three-dimensional (3D) virtual modeling, TASSEP can be feasibly performed on selected patients with satisfactory success rates and low complication rates, providing preferable cosmetic results and alleviating the surgical burden to a certain extent.